{
    "clinical_study": {
        "@rank": "43529", 
        "acronym": "PAAT", 
        "arm_group": [
            {
                "arm_group_label": "Pecutaneous AF ablation", 
                "arm_group_type": "Active Comparator", 
                "description": "Percutaneous catheter ablation of atrial fibrillation"
            }, 
            {
                "arm_group_label": "Surgical AF ablation", 
                "arm_group_type": "Active Comparator", 
                "description": "Minimally invasive thoracoscopic surgical ablation of atrial fibrillation"
            }
        ], 
        "brief_summary": {
            "textblock": "Persistent atrial fibrillation (AF) is a common and distressing condition, that can cause\n      significant symptoms. AF ablation is a recognised technique to treat persistent AF, but can\n      be technically difficult. This study compares percutaneous ablation to thoracoscopic\n      surgical AF ablation."
        }, 
        "brief_title": "Persistent Atrial Fibrillation Ablation Trial", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Symptomatic persistent or long-standing AF suitable for AF ablation.\n\n          -  Age over 18 years old.\n\n          -  Informed consent to participate in this study.\n\n        Exclusion Criteria:\n\n          -  Pre-existing ILRs or permanent pacemakers that do not allow for continuous monitoring\n             for AF occurrence, or are not MRI-safe.\n\n          -  Unable to undergo general anaesthesia for AF ablation.\n\n          -  Previous cardiac surgery, such as coronary artery bypass grafting or valvular\n             surgery.\n\n          -  Scheduled for elective cardiac surgery, such as coronary artery bypass grafting or\n             valvular surgery.\n\n          -  Previous thoracic surgery.\n\n          -  Participation in a conflicting study.\n\n          -  Potential participants who are mentally incapacitated and cannot consent or comply\n             with follow-up\n\n          -  Pregnancy\n\n          -  Other cardiac rhythm disorders"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01891825", 
            "org_study_id": "PAAT"
        }, 
        "intervention": [
            {
                "arm_group_label": "Surgical AF ablation", 
                "description": "Minimally invasive thoracoscopic surgical ablation of atrial fibrillation", 
                "intervention_name": "Surgical AF ablation", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Pecutaneous AF ablation", 
                "description": "Percutaneous catheter ablation of atrial fibrillation", 
                "intervention_name": "Percutaneous AF ablation", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Atrial fibrillation", 
            "Persistent atrial fibrillation", 
            "Atrial fibrillation ablation"
        ], 
        "lastchanged_date": "June 29, 2013", 
        "location": [
            {
                "contact": {
                    "email": "conn.sugihara@esht.nhs.uk", 
                    "last_name": "Conn Sugihara, MBBS", 
                    "phone": "01323 417400", 
                    "phone_ext": "5869"
                }, 
                "facility": {
                    "address": {
                        "city": "Eastbourne", 
                        "country": "United Kingdom", 
                        "state": "E Sussex", 
                        "zip": "BN21 2UD"
                    }, 
                    "name": "Eastbourne General Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Neil Sulke, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Steve Furniss, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "conn.sugihara@esht.nhs.uk", 
                    "last_name": "Conn Sugihara, MBBS", 
                    "phone": "01323 417400", 
                    "phone_ext": "5869"
                }, 
                "facility": {
                    "address": {
                        "city": "Brighton", 
                        "country": "United Kingdom", 
                        "state": "East Sussex", 
                        "zip": "BN2 5BE"
                    }, 
                    "name": "Royal Sussex County Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Jonathan Hyde, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Michael Lewis, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "Persistent Atrial Fibrillation Ablation Trial", 
        "other_outcome": [
            {
                "measure": "Quality of life changes after AF ablation", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Change in exercise capacity assessed by cardiopulmonary exercise testing (CPET) after AF ablation", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Change in echocardiographic left atrial dimensions and function after AF ablation", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Change in cognitive function as assessed by the Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) instruments", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "overall_contact": {
            "email": "conn.sugihara@esht.nhs.uk", 
            "last_name": "Conn Sugihara, MBBS", 
            "phone": "+44 1323 417400", 
            "phone_ext": "5869"
        }, 
        "overall_official": {
            "affiliation": "Eastbourne General Hospital", 
            "last_name": "Neil Sulke, DM", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: National Health Service", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Mean time to recurrence of persistent AF after ablation", 
            "measure": "Recurrence of persistent AF by 12 months after ablation", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01891825"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Eastbourne General Hospital", 
            "investigator_full_name": "Neil Sulke", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Detected by ILR", 
                "measure": "Change in AF burden after AF ablation", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Time to first episode of symptomatic AF after ablation", 
                "measure": "Time to first episode of symptomatic AF after ablation", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "As detected by ILR", 
                "measure": "Time to first episode of any AF after ablation", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "As detected by ILR, outside blanking period", 
                "measure": "Total number of AF episodes after AF ablation", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "As detected by ILR, outside blanking period", 
                "measure": "Total number of AF episodes lasting greater than 6 minutes after AF ablation", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "New MRI-detected subclinical cerebral embolic events", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "source": "Eastbourne General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Neil Sulke", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}